← Insider buys
ALXN

Alexion Pharmaceuticals, Inc.

EVP and Chief Commercial Officer Brian Goff sold $192K of Alexion Pharmaceuticals, Inc.

Sold$192,028
$116.31Price
1,651Shares
−5%Stake

What ALXN did after the filing

Prices for ALXN after this filing aren't in yet.

Traded Thu, Feb 8. Filed Thu, Feb 8, 7:17 PM ET, after the close. Not investment advice.